AI is the way forward 

I’ve been buying $Tempus AI(TEM)$ in the $40 range I think this stock can do some big gains based on AI growing at a rapid pace and this specifically being in the healthcare field plus they are receiving government grants and the best trader on the planet Nancy Pelosi is in.

💰 In the world of short-term investing, stories, news, and unexpected events are the secrets of investing.💹 Event-driven markets usually last for a few days or less. As long as you are not the last one to get on the train, you will not lose money, but this requires the ability to resist greed.📣 Stay tuned and supercharge purchasing power with CashBoost!IntroductionAs the penetration rate of AI in the industry continues to increase, more and more industries have announced the use of AI to empower their own businesses, such as AI Powered Healthcare, AI Powered Education, etc.Last week, on February 13, President Trump signed an executive order to establish the "MAHA" (Make America Healthy Again) committee. Although Trump is known for his "around-the-clock" governance style, with his "Twitter-

💰 U.S. market maintains upward trajectory, with Meta setting a new record — rising for 19 consecutive trading days.💹 $Airbnb, Inc.(ABNB)$ , $Upwork Inc.(UPWK)$ , and $Fiverr International Ltd.(FVRR)$ are emerging as highly attractive opportunities, offering substantial value for investors.📣Stay tuned, supercharge purchasing power through CashBoost!————————————————————————————————————————————————| Market recapThe U.S. stock market opened strong and closed higher across all three major indices. $Meta Platforms, Inc.(META)$ continues its impressive upward streak, breaking records with 19 consecutive days of gains. Additiona

Traders May Finally get the chance to BUY $Tempus AI(TEM)$ at same cost level as Nancy Pelosi likely today

Industry-Leading Growth & Innovation $Hims & Hers Health Inc.(HIMS)$  is not just another name in the telehealth space; it's a beacon of innovation and growth, boasting the fastest revenue growth in its sector. With a revenue surge to $401.6 million in Q3, up 77% year-over-year, Hims is on a trajectory that could see its value triple, if not more. This growth is underpinned by a unique business model: Direct-to-Consumer (DTC) Focus targeting Millennials & Gen Z. Specialized Services in telemedicine, weight loss, hair loss, skincare, sexual health, and mental health. One-Stop Healthcare solution with its online pharmacy, handling consultation to prescription fulfillment. Personalized Treatment using A

The rise of artificial intelligence (AI) has already transformed industries, but a new wave of innovation—agentic AI—is emerging as a game-changer. Unlike traditional AI systems that follow predefined rules or react to inputs, agentic AI refers to autonomous systems capable of making decisions, learning dynamically, and acting independently in complex environments. From healthcare to logistics, companies leveraging agentic AI are positioned to disrupt markets and generate outsized returns. In this article, I would like to discuss why agentic AI stocks are set to thrive in the coming decade. The Evolution from Assistive to Autonomous AI Traditional AI excels at pattern recognition (e.g., ChatGPT for text generation), but agentic AI goes further by enabling machines to set goals, adapt to un

In recent years, particularly during the economic turbulence caused by the global health crisis, options trading has surged in popularity among retail investors in the United States. Data from the Options Clearing Corporation shows that during the peak of the epidemic, the volume of options traded soared, with daily average trading volumes in 2020 increasing by about 50% compared to the previous year. However, this increase in activity has not universally led to success; statistics suggest that approximately 80% of retail options traders end up losing money, with average losses often exceeding initial investments by significant margins. According to a 2022 report by the Financial Industry Regulatory Authority (FINRA), only about 20% of retail investors consistently profited from optio

Hims & Hers Stock Is On Fire. Is It a Meme? $Hims & Hers Health Inc.(HIMS)$ has been in the Asymmetric Universe since May 24, 2024, when this Spotlight article was published. I thought the company had 10x potential over the next decade, disrupting how we think about getting medicine in an internet world.What I didn’t expect was for shares to be up 258.2% in just under 9 months and 142.1% this year alone.Has the stock become a meme? Is buying now crazy? Or is the rocket ship just taking off?Hims & Hers Growth Is Out of This WorldSince 2018, Hims & Hers has grown revenue at a 95% compound annual growth rate and expects to grow revenue 90% this quarter. There aren’t many companies growing that fast and improving profitability at the s

1. Pelosi makes a ton of new trades before Trumps inauguration day!According to Securities and Exchange Commission (SEC) files:$Alphabet(GOOG)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $150, exp. date 1/16/26$Amazon.com(AMZN)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $150, exp. date 1/16/26$NVIDIA(NVDA)$ Buy (Call) / $250K - $500K / Purchased 50 call options, strike price $80, exp. date 1/16/26$Vistra Energy Corp.(VST)$ Buy (Call) / $500K - $1M / Purchased 50 call options, strike price $50, exp. date 1/16/26$Tempus AI(TEM

$Tempus AI(TEM)$ TEM's earnings outlook remains robust, supporting high estimates, especially within the AI + health sector. Here’s why:1. AI Integration in Healthcare: TEM’s focus on integrating AI into healthcare solutions positions it well for growth. As AI continues to revolutionize diagnostics, treatment recommendations, and patient management, TEM stands to benefit from expanding market opportunities, especially in telemedicine and AI-driven medical tools.2. Strong Earnings Growth: TEM has shown consistent earnings growth, with solid performance in both AI and healthcare segments. This foundation gives confidence that the company can meet or exceed analyst estimates. The scalability of their AI-powered solutions also

$Tempus AI(TEM)$ $SUPER MICRO COMPUTER INC(SMCI)$ 📈🅱️ U͛ L͛ L͛ I͛ S͛ H͛🔺💹  🎯🎉 $TEM: The Biotech Vanguard I Identified First, AI Innovation Meets Pelosi’s Power Strategy, Echoing SMCI’s Ascendancy! 🎉🎯 Tiger Traders, back on 11Dec24, I spotlighted $TEM as more than just a stock, it was a harbinger of change. Now, with the industry’s eyes on it, $TEM is not just innovating, it’s leading a healthcare revolution, reminiscent of SMCI’s transformative journey in tech. 📈 TEM’s Unparalleled Ascendancy: 1️⃣ Pharma’s Cornerstone: Tempus isn’t merely contributing, it’s orchestrating the future of drug development for 95% of the globe’s pharmaceutical leaders. This isn’t just influence, it’s control. 🌍💊 2️⃣ AI Hea

‌$Tempus AI(TEM)$  ‌ Tempus AI: Balancing Innovation and Profitability – Is It Time to Buy, Hold, or Sell? Here's the approach: Evaluate Financial Position: Analyze Tempus AI’s revenue growth, profitability, cash reserves, and spending patterns (e.g., R&D, stock-based compensation). Consider Strategic Developments: Assess recent news, including the Ambry Genetics acquisition and product launches, to understand how they enhance Tempus’ competitive edge. Compare Market Price to Valuation: Use the company’s performance metrics and the stock’s current price ($47.64) to judge whether it’s undervalued, fairly priced, or overvalued. Risk Analysis: Identify key risks (e.g., declining genomics margins, operational losses) to gauge long-term sustain